Organon (OGN) Operating Expenses (2020 - 2026)

Organon (OGN) has reported Operating Expenses for 7 consecutive years, with $548.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Operating Expenses fell 8.97% year-over-year to $548.0 million; the TTM figure through Mar 2026 stood at $2.1 billion (down 6.46% YoY), while the FY2025 annual figure was $2.2 billion, down 3.45% from the prior year.
• Operating Expenses came in at $548.0 million for Q1 2026 at Organon, up from $531.0 million in the prior quarter.
• The five-year high for Operating Expenses was $1.5 billion in Q4 2023, with the low at $499.0 million in Q3 2025.
• Average Operating Expenses over 5 years is $966.5 million, with a median of $1.1 billion recorded in 2022.
• Across the five-year window, Operating Expenses grew 15.82% in 2023 and plunged 64.42% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $1.4 billion in 2022, then increased by 8.73% to $1.5 billion in 2023, then tumbled by 59.3% to $608.0 million in 2024, then slipped by 12.66% to $531.0 million in 2025, then increased by 3.2% to $548.0 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $548.0 million, $531.0 million, and $499.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.